Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate after kidney transplantation for prevention of bone loss and vascular calcification
2004-002852-33Phase 4Active
- Sponsor
- Dr. Jose Vicente Torregrosa Prats (fundacio clinic)
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of risedronate sodium in chronic kidney disease-mineral and bone disorder (CKD-MBD) (2 arms), sponsored by Dr. Jose Vicente Torregrosa Prats (fundacio clinic). Primary endpoint: Bone mass evolution by densitometry. Started Jan 2006; status: active.
02
Drugs
risedronate sodium
03
Conditions
chronic kidney disease-mineral and bone disorder (CKD-MBD)
Beyond the preview
Go deeper on 2004-002852-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002852-33.